Pharmacokinetics of Oral CK-1827452 in Patients With Stable Heart Failure

计划入组 35 人 · 首次发布于 2009 年 7 月 17 日

IMPAACT P1073: Study of IRIS for Infants and Children Initiating HAART at Int'l Sites

计划入组 207 人 · 首次发布于 2010 年 11 月 15 日

Phase II Study of the Effect of CK-1827452 Injection on Myocardial Efficiency

计划入组 2 人 · 首次发布于 2008 年 9 月 8 日

PD-L1 peptide vaccines(CK Life Sciences)

Epoetin alfa biosimilar (LG Life Sciences)

CKBP-002

Achieve Life Sciences, Inc

Canada

RPG LIFE SCIENCES LIMITED

India

SELLAS LIFE SCIENCES LIMITED

Ireland

CK Life Sciences Establishes Sequencio Therapeutics to Advance Therapeutic Cancer Vaccine Portfolio

TransCode Therapeutics Acquires Polynoma in $25 Million Deal to Advance Phase 3-Ready Melanoma Vaccine

Dogwood Therapeutics Secures $26.8M Financing and Files New IP Protection for Synthetic Halneuron Through 2045